世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の臨床用質量分析計市場の洞察、2027年までの予測


Global Clinical Mass Spectrometry Market Insights, Forecast to 2027

市場分析と洞察。臨床用質量分析装置の世界市場 臨床用質量分析計の世界市場は、2020年に760.3百万米ドルとなっています。2021-2027年の間に10.1%のCAGRで成長し、2027年末には市場規模が1億4,800万米ドルに達す... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2022年1月20日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

市場分析と洞察。臨床用質量分析装置の世界市場
臨床用質量分析計の世界市場は、2020年に760.3百万米ドルとなっています。2021-2027年の間に10.1%のCAGRで成長し、2027年末には市場規模が1億4,800万米ドルに達する見込みです。
世界の臨床用質量分析装置のスコープとセグメント
臨床用質量分析装置市場は、タイプ別、アプリケーション別に分類されます。世界のClinical Mass Spectrometry市場に参加するプレイヤーやステークホルダーなどは、このレポートを強力なリソースとして活用することで、優位に立つことができます。セグメント分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。
企業別
ダナハー
Bruker（ブルカー
アジレント
サーモフィッシャー
ウォーターズ
シドーマツ
パーキンエルマー
タイプ別
LC-MS
MALDI-TOF MS
その他
アプリケーション別
臨床診断
臨床研究
地域別
北アメリカ
アメリカ
カナダ
メキシコ

アジア太平洋
中国
日本
韓国
インド
オーストラリア
東南アジア

ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア

南米
ブラジル

中近東・アフリカ
中近東
アフリカ

ページTOPに戻る


目次

1 STUDY COVERAGE 1
1.1 Clinical Mass Spectrometry Product Introduction 1
1.2 Market Segments 1
1.3 Key Manufacturers Covered 2
1.4 Market by Type 2
1.4.1 Global Clinical Mass Spectrometry Market Size Growth Rate by Type 2
1.4.2 LC-MS 4
1.4.3 MALDI-TOF MS 5
1.5 Market by Application 6
1.5.1 Global Clinical Mass Spectrometry Market Size Growth Rate by Application 6
1.5.2 Clinical Diagnostics 7
1.5.3 Clinical Research 8
1.6 Study Objectives 8
1.7 Years Considered 9
2 EXECUTIVE SUMMARY 10
2.1 Global Clinical Mass Spectrometry Market Size 10
2.1.1 Global Clinical Mass Spectrometry Revenue 2016-2027 10
2.1.2 Global Clinical Mass Spectrometry Sales 2016-2027 10
2.2 Clinical Mass Spectrometry Growth Rate by Region 11
2.2.1 Global Clinical Mass Spectrometry Sales by Region 12
2.2.2 Global Clinical Mass Spectrometry Revenue by Region 14
3 BREAKDOWN DATA BY MANUFACTURER 16
3.1 Clinical Mass Spectrometry Sales by Manufacturer 16
3.1.1 Clinical Mass Spectrometry Sales by Manufacturer 16
3.1.2 Clinical Mass Spectrometry Sales Market Share by Manufacturer 16
3.2 Clinical Mass Spectrometry Revenue by Manufacturer 17
3.2.1 Clinical Mass Spectrometry Revenue by Manufacturer (2019-2021) 17
3.2.2 Clinical Mass Spectrometry Revenue Share by Manufacturer (2019-2021) 18
3.2.3 Global Market Concentration Ratio (CR5 and HHI) 19
3.3 Clinical Mass Spectrometry Price by Manufacturer 20
3.4 Clinical Mass Spectrometry Sales Areas, Headquarters, Product Types 20
3.4.1 Clinical Mass Spectrometry Manufacturers Sales Areas, Headquarters 20
3.4.2 Manufacturers Clinical Mass Spectrometry Product Type 20
3.4.3 Founded Date of International Clinical Mass Spectrometry Manufacturers 21
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 21
4 BREAKDOWN DATA BY TYPE 24
4.1 Global Clinical Mass Spectrometry Sales by Type 24
4.2 Global Clinical Mass Spectrometry Revenue by Type 25
4.3 Clinical Mass Spectrometry Price by Type 27
5 BREAKDOWN DATA BY APPLICATION 28
5.1 Overview 28
5.2 Global Clinical Mass Spectrometry Breakdown Data by Application 28
6 NORTH AMERICA 30
6.1 North America Clinical Mass Spectrometry by Country 31
6.1.1 North America Clinical Mass Spectrometry Sales by Country 31
6.1.2 North America Clinical Mass Spectrometry Revenue by Country 32
6.1.3 United States 33
6.1.4 Canada 34
6.1.5 Mexico 35
6.2 North America Clinical Mass Spectrometry by Type 36
6.3 North America Clinical Mass Spectrometry by Application 37
7 EUROPE 38
7.1 Europe Clinical Mass Spectrometry by Country 39
7.1.1 Europe Clinical Mass Spectrometry Sales by Country 39
7.1.2 Europe Clinical Mass Spectrometry Revenue by Country 40
7.1.3 Germany 41
7.1.4 France 42
7.1.5 UK 43
7.1.6 Italy 44
7.1.7 Russia 45
7.2 Europe Clinical Mass Spectrometry by Type 46
7.3 Europe Clinical Mass Spectrometry by Application 47
8 ASIA PACIFIC 49
8.1 Asia Pacific Clinical Mass Spectrometry by Region 50
8.1.1 Asia Pacific Clinical Mass Spectrometry Sales by Region 50
8.1.2 Asia Pacific Clinical Mass Spectrometry Revenue by Region 51
8.1.3 China 52
8.1.4 Japan 53
8.1.5 South Korea 54
8.1.6 India 55
8.1.7 Australia 56
8.1.8 Southeast Asia 57
8.2 Asia Pacific Clinical Mass Spectrometry by Type 58
8.3 Asia Pacific Clinical Mass Spectrometry by Application 59
9 SOUTH AMERICA 61
9.1 South America Clinical Mass Spectrometry by Country 62
9.1.1 South America Clinical Mass Spectrometry Sales by Country 62
9.1.2 South America Clinical Mass Spectrometry Revenue by Country 63
9.1.3 Brazil 64
9.2 South America Clinical Mass Spectrometry by Type 65
9.3 South America Clinical Mass Spectrometry by Application 66
10 MIDDLE EAST AND AFRICA 67
10.1 Middle East and Africa Clinical Mass Spectrometry by Country 68
10.1.1 Middle East and Africa Clinical Mass Spectrometry Sales by Country 68
10.1.2 Middle East and Africa Clinical Mass Spectrometry Revenue by Country 69
10.1.3 Middle East 70
10.1.4 Africa 71
10.2 Middle East and Africa Clinical Mass Spectrometry by Type 72
10.3 Middle East and Africa Clinical Mass Spectrometry by Application 73
11 MAJOR MANUFACTURERS ANALYSIS OF CLINICAL MASS SPECTROMETRY 74
11.1 Danaher 74
11.1.1 Company Profile 74
11.1.2 Product Picture and Specifications 75
11.1.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 77
11.1.4 Contact Information 78
11.2 Bruker 78
11.2.1 Company Profile 78
11.2.2 Product Picture and Specifications 79
11.2.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 80
11.2.4 Contact Information 80
11.3 Agilent 81
11.3.1 Company Profile 81
11.3.2 Product Picture and Specifications 81
11.3.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 84
11.3.4 Contact Information 84
11.4 Thermo Fisher 85
11.4.1 Company Profile 85
11.4.2 Product Picture and Specifications 85
11.4.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 89
11.4.4 Contact Information 90
11.5 Waters 90
11.5.1 Company Profile 90
11.5.2 Product Picture and Specifications 91
11.5.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 93
11.5.4 Contact Information 94
11.6 Shimadzu 94
11.6.1 Company Profile 94
11.6.2 Product Picture and Specifications 95
11.6.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 96
11.6.4 Contact Information 96
11.7 PerkinElmer 97
11.7.1 Company Profile 97
11.7.2 Product Picture and Specifications 97
11.7.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 98
11.7.4 Contact Information 99
12 CLINICAL MASS SPECTROMETRY MANUFACTURING COST ANALYSIS 100
12.1 Basic Structure of Mass Spectrometry Systems 100
12.2 Key Raw Materials Analysis 101
12.2.1 Key Raw Materials 101
12.2.2 Key Suppliers of Raw Materials 101
12.3 Proportion of Manufacturing Cost Structure 102
13 FUTURE FORECAST 104
13.1 Clinical Mass Spectrometry Market Forecast by Region 104
13.1.1 Global Clinical Mass Spectrometry Sales Forecast by Region (2022-2027) 104
13.1.2 Global Clinical Mass Spectrometry Revenue Forecast by Region (2022-2027) 104
13.2 Clinical Mass Spectrometry Market Forecast by Type 105
13.2.1 Global Clinical Mass Spectrometry Sales Forecast by Type (2022-2027) 105
13.2.2 Global Clinical Mass Spectrometry Revenue Forecast by Type (2022-2027) 106
13.3 Clinical Mass Spectrometry Market Forecast by Application 106
13.4 North America Clinical Mass Spectrometry Forecast 107
13.5 Europe Clinical Mass Spectrometry Forecast 108
13.6 Asia Pacific Clinical Mass Spectrometry Forecast 109
13.7 South America Clinical Mass Spectrometry Forecast 110
13.8 Middle East and Africa Clinical Mass Spectrometry Forecast 111
14 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 112
14.1 Clinical Mass Spectrometry Industry Trends 112
14.2 Market Opportunities and Drivers 113
14.3 Market Challenges 114
14.4 Porter鈥檚 Five Forces Analysis 114
15 VALUE CHAIN AND SALES CHANNELS ANALYSIS 116
15.1 Value Chain Analysis 116
15.2 Clinical Mass Spectrometry Customers 117
15.3 Sales Channels Analysis 118
15.3.1 Sales Channels 118
15.3.2 Distributors 119
16 FACTORS INFLUENCING 122
16.1 Macro-Economic Factors 122
16.2 Price Trend of Key Industrial Raw Material 124
16.2.1 Oil & Gas 124
16.2.2 Mineral and Metal 126
17 RESEARCH FINDINGS AND CONCLUSION 129
18 APPENDIX 131
18.1 Research Methodology 131
18.1.1 Methodology/Research Approach 131
18.1.2 Data Source 134
18.2 Author Details 137
18.3 Disclaimer 138

　

ページTOPに戻る


　

Summary

Market Analysis and Insights: Global Clinical Mass Spectrometry Market
The global Clinical Mass Spectrometry market is valued at US$ 760.3 million in 2020. The market size will reach US$ 1484 million by the end of 2027, growing at a CAGR of 10.1% during 2021-2027.
Global Clinical Mass Spectrometry Scope and Segment
Clinical Mass Spectrometry market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Mass Spectrometry market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2016-2027.
By Company
Danaher
Bruker
Agilent
Thermo Fisher
Waters
Shidmazu
Perkin Elmer
By Type
LC-MS
MALDI-TOF MS
Other
By Application
Clinical Diagnostics
Clinical Research
By Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia

Europe
Germany
France
UK
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa



ページTOPに戻る


Table of Contents

1 STUDY COVERAGE 1
1.1 Clinical Mass Spectrometry Product Introduction 1
1.2 Market Segments 1
1.3 Key Manufacturers Covered 2
1.4 Market by Type 2
1.4.1 Global Clinical Mass Spectrometry Market Size Growth Rate by Type 2
1.4.2 LC-MS 4
1.4.3 MALDI-TOF MS 5
1.5 Market by Application 6
1.5.1 Global Clinical Mass Spectrometry Market Size Growth Rate by Application 6
1.5.2 Clinical Diagnostics 7
1.5.3 Clinical Research 8
1.6 Study Objectives 8
1.7 Years Considered 9
2 EXECUTIVE SUMMARY 10
2.1 Global Clinical Mass Spectrometry Market Size 10
2.1.1 Global Clinical Mass Spectrometry Revenue 2016-2027 10
2.1.2 Global Clinical Mass Spectrometry Sales 2016-2027 10
2.2 Clinical Mass Spectrometry Growth Rate by Region 11
2.2.1 Global Clinical Mass Spectrometry Sales by Region 12
2.2.2 Global Clinical Mass Spectrometry Revenue by Region 14
3 BREAKDOWN DATA BY MANUFACTURER 16
3.1 Clinical Mass Spectrometry Sales by Manufacturer 16
3.1.1 Clinical Mass Spectrometry Sales by Manufacturer 16
3.1.2 Clinical Mass Spectrometry Sales Market Share by Manufacturer 16
3.2 Clinical Mass Spectrometry Revenue by Manufacturer 17
3.2.1 Clinical Mass Spectrometry Revenue by Manufacturer (2019-2021) 17
3.2.2 Clinical Mass Spectrometry Revenue Share by Manufacturer (2019-2021) 18
3.2.3 Global Market Concentration Ratio (CR5 and HHI) 19
3.3 Clinical Mass Spectrometry Price by Manufacturer 20
3.4 Clinical Mass Spectrometry Sales Areas, Headquarters, Product Types 20
3.4.1 Clinical Mass Spectrometry Manufacturers Sales Areas, Headquarters 20
3.4.2 Manufacturers Clinical Mass Spectrometry Product Type 20
3.4.3 Founded Date of International Clinical Mass Spectrometry Manufacturers 21
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 21
4 BREAKDOWN DATA BY TYPE 24
4.1 Global Clinical Mass Spectrometry Sales by Type 24
4.2 Global Clinical Mass Spectrometry Revenue by Type 25
4.3 Clinical Mass Spectrometry Price by Type 27
5 BREAKDOWN DATA BY APPLICATION 28
5.1 Overview 28
5.2 Global Clinical Mass Spectrometry Breakdown Data by Application 28
6 NORTH AMERICA 30
6.1 North America Clinical Mass Spectrometry by Country 31
6.1.1 North America Clinical Mass Spectrometry Sales by Country 31
6.1.2 North America Clinical Mass Spectrometry Revenue by Country 32
6.1.3 United States 33
6.1.4 Canada 34
6.1.5 Mexico 35
6.2 North America Clinical Mass Spectrometry by Type 36
6.3 North America Clinical Mass Spectrometry by Application 37
7 EUROPE 38
7.1 Europe Clinical Mass Spectrometry by Country 39
7.1.1 Europe Clinical Mass Spectrometry Sales by Country 39
7.1.2 Europe Clinical Mass Spectrometry Revenue by Country 40
7.1.3 Germany 41
7.1.4 France 42
7.1.5 UK 43
7.1.6 Italy 44
7.1.7 Russia 45
7.2 Europe Clinical Mass Spectrometry by Type 46
7.3 Europe Clinical Mass Spectrometry by Application 47
8 ASIA PACIFIC 49
8.1 Asia Pacific Clinical Mass Spectrometry by Region 50
8.1.1 Asia Pacific Clinical Mass Spectrometry Sales by Region 50
8.1.2 Asia Pacific Clinical Mass Spectrometry Revenue by Region 51
8.1.3 China 52
8.1.4 Japan 53
8.1.5 South Korea 54
8.1.6 India 55
8.1.7 Australia 56
8.1.8 Southeast Asia 57
8.2 Asia Pacific Clinical Mass Spectrometry by Type 58
8.3 Asia Pacific Clinical Mass Spectrometry by Application 59
9 SOUTH AMERICA 61
9.1 South America Clinical Mass Spectrometry by Country 62
9.1.1 South America Clinical Mass Spectrometry Sales by Country 62
9.1.2 South America Clinical Mass Spectrometry Revenue by Country 63
9.1.3 Brazil 64
9.2 South America Clinical Mass Spectrometry by Type 65
9.3 South America Clinical Mass Spectrometry by Application 66
10 MIDDLE EAST AND AFRICA 67
10.1 Middle East and Africa Clinical Mass Spectrometry by Country 68
10.1.1 Middle East and Africa Clinical Mass Spectrometry Sales by Country 68
10.1.2 Middle East and Africa Clinical Mass Spectrometry Revenue by Country 69
10.1.3 Middle East 70
10.1.4 Africa 71
10.2 Middle East and Africa Clinical Mass Spectrometry by Type 72
10.3 Middle East and Africa Clinical Mass Spectrometry by Application 73
11 MAJOR MANUFACTURERS ANALYSIS OF CLINICAL MASS SPECTROMETRY 74
11.1 Danaher 74
11.1.1 Company Profile 74
11.1.2 Product Picture and Specifications 75
11.1.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 77
11.1.4 Contact Information 78
11.2 Bruker 78
11.2.1 Company Profile 78
11.2.2 Product Picture and Specifications 79
11.2.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 80
11.2.4 Contact Information 80
11.3 Agilent 81
11.3.1 Company Profile 81
11.3.2 Product Picture and Specifications 81
11.3.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 84
11.3.4 Contact Information 84
11.4 Thermo Fisher 85
11.4.1 Company Profile 85
11.4.2 Product Picture and Specifications 85
11.4.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 89
11.4.4 Contact Information 90
11.5 Waters 90
11.5.1 Company Profile 90
11.5.2 Product Picture and Specifications 91
11.5.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 93
11.5.4 Contact Information 94
11.6 Shimadzu 94
11.6.1 Company Profile 94
11.6.2 Product Picture and Specifications 95
11.6.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 96
11.6.4 Contact Information 96
11.7 PerkinElmer 97
11.7.1 Company Profile 97
11.7.2 Product Picture and Specifications 97
11.7.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 98
11.7.4 Contact Information 99
12 CLINICAL MASS SPECTROMETRY MANUFACTURING COST ANALYSIS 100
12.1 Basic Structure of Mass Spectrometry Systems 100
12.2 Key Raw Materials Analysis 101
12.2.1 Key Raw Materials 101
12.2.2 Key Suppliers of Raw Materials 101
12.3 Proportion of Manufacturing Cost Structure 102
13 FUTURE FORECAST 104
13.1 Clinical Mass Spectrometry Market Forecast by Region 104
13.1.1 Global Clinical Mass Spectrometry Sales Forecast by Region (2022-2027) 104
13.1.2 Global Clinical Mass Spectrometry Revenue Forecast by Region (2022-2027) 104
13.2 Clinical Mass Spectrometry Market Forecast by Type 105
13.2.1 Global Clinical Mass Spectrometry Sales Forecast by Type (2022-2027) 105
13.2.2 Global Clinical Mass Spectrometry Revenue Forecast by Type (2022-2027) 106
13.3 Clinical Mass Spectrometry Market Forecast by Application 106
13.4 North America Clinical Mass Spectrometry Forecast 107
13.5 Europe Clinical Mass Spectrometry Forecast 108
13.6 Asia Pacific Clinical Mass Spectrometry Forecast 109
13.7 South America Clinical Mass Spectrometry Forecast 110
13.8 Middle East and Africa Clinical Mass Spectrometry Forecast 111
14 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 112
14.1 Clinical Mass Spectrometry Industry Trends 112
14.2 Market Opportunities and Drivers 113
14.3 Market Challenges 114
14.4 Porter鈥檚 Five Forces Analysis 114
15 VALUE CHAIN AND SALES CHANNELS ANALYSIS 116
15.1 Value Chain Analysis 116
15.2 Clinical Mass Spectrometry Customers 117
15.3 Sales Channels Analysis 118
15.3.1 Sales Channels 118
15.3.2 Distributors 119
16 FACTORS INFLUENCING 122
16.1 Macro-Economic Factors 122
16.2 Price Trend of Key Industrial Raw Material 124
16.2.1 Oil & Gas 124
16.2.2 Mineral and Metal 126
17 RESEARCH FINDINGS AND CONCLUSION 129
18 APPENDIX 131
18.1 Research Methodology 131
18.1.1 Methodology/Research Approach 131
18.1.2 Data Source 134
18.2 Author Details 137
18.3 Disclaimer 138

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（mass spectrometry）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/08/02　10:26

150.52 円

162.85 円

194.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.